Amgen Inc. Stock Climbs 4.6%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Amgen Inc. advanced 4.6% to $407.83 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.5% to 54,349.12 and the S&P 500 Index falling 0.2% to 7,723.55.

This was the stock's second consecutive day of gains.

Amgen Inc. hit a new 52-week high, surpassing its previous peak of $398.00, which the company reached on July 28th.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.0% to $257.59, Pfizer Inc. rose 1.6% to $25.81, and AbbVie Inc. rose 0.98% to $246.20.

Trading volume totaled 5.6 million, compared to the 50-day average of 2.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 05, 2026 16:35 ET (20:35 GMT)